Related scientific articles (all)

Randomized Phase II Study of the Anti-Epidermal Growth Factor Receptor Monoclonal Antibody Cetuximab With Cisplatin Versus Cisplatin Alone in Patients With Metastatic Triple-Negative Breast Cancer.

Authors : Baselga J, Gómez P, Greil R, Braga S, Climent MA, Wardley AM, Kaufman B, Stemmer SM, Pêgo A, Chan A, Goeminne JC, Graas MP, Kennedy MJ, Ciruelos Gil EM, Schneeweiss A, Zubel A, Groos J, Melezínková H, Awada A
Year : 2013
Journal : J. Clin. Oncol.
Volume : 31(20)
Pages : 2586-92

Sequential use of protein kinase inhibitors potentiates their toxicity to melanoma cells: A rationale to combine targeted drugs based on protein expression inhibition profiles.

Authors : Aftimos P, Wiedig M, Langouo Fontsa M, Awada A, Ghanem G, Journe F
Year : 2013
Journal : Int J Oncol
Volume : 43(3)
Pages : 919-26

PIK3CA genotype and a PIK3CA mutation-related gene signature and response to everolimus and letrozole in estrogen receptor positive breast cancer.

Authors : Loi S, Michiels S, Baselga J, Bartlett JM, Singhal SK, Sabine VS, Sims AH, Sahmoud T, Dixon JM, Piccart-Gebhart M, Sotiriou C
Year : 2013
Journal : PLoS One
Volume : 8(1)
Pages : e53292

Targeting RANKL in breast cancer: bone metastasis and beyond.

Authors : Azim H, Azim HA
Year : 2013
Journal : Expert Rev Anticancer Ther
Volume : 13(2)
Pages : 195-201

Additional prognostic value of the 70-gene signature (MammaPrint(®)) among breast cancer patients with 4-9 positive lymph nodes.

Authors : Saghatchian M, Mook S, Pruneri G, Viale G, Glas AM, Guerin S, Cardoso F, Piccart-Gebhart M, Tursz T, Delaloge S, van t Veer L
Year : 2013
Journal : Breast
Volume : 22(5)
Pages : 682-90

Utility of prognostic genomic tests in breast cancer practice: The IMPAKT 2012 Working Group Consensus Statement.

Authors : Azim HA, Michiels S, Zagouri F, Delaloge S, Filipits M, Namer M, Neven P, Symmans WF, Thompson A, André F, Loi S, Swanton C
Year : 2013
Journal : Ann Oncol
Volume : 24(3)
Pages : 647-54

Multigene assays for late recurrence of breast cancer.

Authors : Ignatiadis M
Year : 2013
Journal : Lancet Oncol
Volume : 14(11)
Pages : 1029-30

Breast cancer in young women - Special Issue.

Authors : Azim HA, Peccatori FA
Year : 2013
Journal : J Thorac Dis
Volume : 5(Suppl 1)
Pages : S1

Effect of Everolimus on Bone Marker Levels and Progressive Disease in Bone in BOLERO-2.

Authors : Gnant M, Baselga J, Rugo HS, Noguchi S, Burris HA, Piccart-Gebhart M, Hortobagyi GN, Eakle J, Mukai H, Iwata H, Geberth M, Hart LL, Hadji P, El-Hashimy M, Rao S, Taran T, Sahmoud T, Lebwohl D, Campone M, Pritchard KI
Year : 2013
Journal : J. Natl. Cancer Inst.
Volume : 105(9)
Pages : 654-63

Chemotherapy, targeted agents, antiemetics and growth-factors in human milk: how should we counsel cancer patients about breastfeeding?

Authors : Pistilli B, Bellettini G, Giovannetti E, Codacci-Pisanelli G, Azim HA, Benedetti G, Sarno MA, Peccatori FA
Year : 2013
Journal : Cancer Treat Rev
Volume : 39(3)
Pages : 207-11

Semiautomated isolation and molecular characterisation of single or highly purified tumour cells from CellSearch enriched blood samples using dielectrophoretic cell sorting.

Authors : Peeters DJ, De Laere B, Van den Eynden GG, Van Laere SJ, Rothé F, Ignatiadis M, Sieuwerts AM, Lambrechts D, Rutten A, van Dam PA, Pauwels P, Peeters M, Vermeulen PB, Dirix LY
Year : 2013
Journal : Br J Cancer
Volume : 108(6)
Pages : 1358-67

HER2 staining intensity in HER2-positive disease: relationship with FISH amplification and clinical outcome in the HERA trial of adjuvant trastuzumab.

Authors : Zabaglo L, Stoss O, Rüschoff J, Zielinski D, Salter J, Arfi M, Bradbury I, Dafni U, Piccart-Gebhart M, Procter M, Dowsett M
Year : 2013
Journal : Ann Oncol
Volume : 24(11)
Pages : 2761-6

Overall survival benefit for sequential doxorubicin-docetaxel compared with concurrent doxorubicin and docetaxel in node-positive breast cancer--8-year results of the Breast International Group 02-98 phase III trial.

Authors : Oakman C, Francis PA, Crown J, Quinaux E, Buyse M, de Azambuja E, Margeli Vila M, Andersson M, Nordenskjöld B, Jakesz R, Thürlimann B, Gutiérrez J, Harvey V, Punzalan L, Dell orto P, Larsimont D, Steinberg I, Gelber Rd, Piccart-Gebhart M, Viale G, Di Leo A
Year : 2013
Journal : Ann Oncol
Volume : 24(5)
Pages : 1203-11

Elucidating prognosis and biology of breast cancer arising in young women using gene expression profiling.

Authors : Azim HA, Michiels S, Bedard PL, Singhal SK, Criscitiello C, Ignatiadis M, Haibe-Kains B, Piccart-Gebhart M, Sotiriou C, Loi S
Year : 2012
Journal : Clin Cancer Res
Volume : 18(5)
Pages : 1341-51

Lesion-based detection of early chemosensitivity using serial static FDG PET/CT in metastatic colorectal cancer.

Authors : Buvat I, Necib H, Garcia C, Wagner A, Vanderlinden B, Emonts P, Hendlisz A, Flamen P
Year : 2012
Journal : Eur J Nucl Med Mol Imaging
Volume : 39(10)
Pages : 1628-34

Characterization and clinical evaluation of CD10+ stroma cells in the breast cancer microenvironment.

Authors : Desmedt C, Majjaj S, Kheddoumi N, Singhal SK, Haibe-Kains B, El Ouriaghli F, Chaboteaux C, Michiels S, Lallemand F, Journe F, Duvillier H, Loi S, Quackenbush J, Dekoninck S, Blanpain C, Lagneaux L, Houhou N, Delorenzi M, Larsimont D, Piccart-Gebhart M, Sotiriou C
Year : 2012
Journal : Clin Cancer Res
Volume : 18(4)
Pages : 1004-14

Serial FDG-PET/CT for early outcome prediction in patients with metastatic colorectal cancer undergoing chemotherapy.

Authors : Hendlisz A, Golfinopoulos V, Garcia C, Covas A, Emonts P, Ameye L, Paesmans M, Deleporte A, Machiels G, Toussaint E, Vanderlinden B, Awada A, Piccart-Gebhart M, Flamen P
Year : 2012
Journal : Ann Oncol
Volume : 23(7)
Pages : 1687-93

A three-gene model to robustly identify breast cancer molecular subtypes.

Authors : Haibe-Kains B, Desmedt C, Loi S, Culhane AC, Bontempi G, Quackenbush J, Sotiriou C
Year : 2012
Journal : J. Natl. Cancer Inst.
Volume : 104(4)
Pages : 311-25

Gene modules and response to neoadjuvant chemotherapy in breast cancer subtypes: a pooled analysis.

Authors : Ignatiadis M, Singhal SK, Desmedt C, Haibe-Kains B, Criscitiello C, Andre F, Loi S, Piccart-Gebhart M, Michiels S, Sotiriou C
Year : 2012
Journal : J. Clin. Oncol.
Volume : 30(16)
Pages : 1996-2004

Molecular biology in breast cancer: Should molecular classifiers be assessed by conventional tools or by gene expression arrays?

Authors : Fumagalli D, Andre F, Piccart-Gebhart M, Sotiriou C, Desmedt C
Year : 2012
Journal : Crit Rev Oncol Hematol
Volume : 84 supl 1
Pages : e58-69